Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Blais

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Current Oncology (Toronto, Ont.)|December 10, 2014
Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitorsV Hirsh, N Blais, R Burkes, et al.
Clinical Nephrology|November 1, 1989
Hemolytic uremic syndrome: glomerular filtration rate, 6 to 11 years later measured by 99mTc DTPA plasma slope clearanceS O'Regan, N Blais, P Russo, et al.
Current Oncology (Toronto, Ont.)|July 17, 2020
Erratum: Therapeutic landscape of metastatic non-small-cell lung cancer in Canada in 2020A Elkrief, P Joubert, M Florescu, et al.
Current Oncology (Toronto, Ont.)|March 29, 2020
Therapeutic landscape of metastatic non-small-cell lung cancer in Canada in 2020A Elkrief, P Joubert, M Florescu, et al.
Thrombosis Research|November 28, 2019
Diagnosis and management of congenital thrombophilia in the era of direct oral anticoagulantsR Alameddine, R Nassabein, G Le Gal, et al.
Current Oncology (Toronto, Ont.)|July 17, 2020
Consensus statement: summary of the Quebec Lung Cancer Network recommendations for prioritizing patients with thoracic cancers in the context of the COVID-19 pandemicN Blais, M Bouchard, M Chinas, et al.
Parasitology Research|May 15, 2021
Trematodes coupled with neonicotinoids: effects on blood cell profiles of a model amphibianM J Gavel, S D Young, N Blais, et al.
Public Health Reports (Washington, D.C. : 1974)|July 1, 1994
Analyzing organizational practices in local health departmentsJ Studnicki, B Steverson, H N Blais, et al.
Blood|July 1, 1996
Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with ageL Busque, R Mio, J Mattioli, et al.
Current Oncology (Toronto, Ont.)|November 23, 2018
Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challengesN A Nixon, N Blais, S Ernst, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Current Oncology (Toronto, Ont.)|December 10, 2014
Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitorsV Hirsh, N Blais, R Burkes, et al.
Clinical Nephrology|November 1, 1989
Hemolytic uremic syndrome: glomerular filtration rate, 6 to 11 years later measured by 99mTc DTPA plasma slope clearanceS O'Regan, N Blais, P Russo, et al.
Current Oncology (Toronto, Ont.)|July 17, 2020
Erratum: Therapeutic landscape of metastatic non-small-cell lung cancer in Canada in 2020A Elkrief, P Joubert, M Florescu, et al.
Current Oncology (Toronto, Ont.)|March 29, 2020
Therapeutic landscape of metastatic non-small-cell lung cancer in Canada in 2020A Elkrief, P Joubert, M Florescu, et al.
Thrombosis Research|November 28, 2019
Diagnosis and management of congenital thrombophilia in the era of direct oral anticoagulantsR Alameddine, R Nassabein, G Le Gal, et al.
Current Oncology (Toronto, Ont.)|July 17, 2020
Consensus statement: summary of the Quebec Lung Cancer Network recommendations for prioritizing patients with thoracic cancers in the context of the COVID-19 pandemicN Blais, M Bouchard, M Chinas, et al.
Parasitology Research|May 15, 2021
Trematodes coupled with neonicotinoids: effects on blood cell profiles of a model amphibianM J Gavel, S D Young, N Blais, et al.
Public Health Reports (Washington, D.C. : 1974)|July 1, 1994
Analyzing organizational practices in local health departmentsJ Studnicki, B Steverson, H N Blais, et al.
Blood|July 1, 1996
Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with ageL Busque, R Mio, J Mattioli, et al.
Current Oncology (Toronto, Ont.)|November 23, 2018
Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challengesN A Nixon, N Blais, S Ernst, et al.
Pageof 6